BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25522110)

  • 1. Structure-based design of bacterial nitric oxide synthase inhibitors.
    Holden JK; Kang S; Hollingsworth SA; Li H; Lim N; Chen S; Huang H; Xue F; Tang W; Silverman RB; Poulos TL
    J Med Chem; 2015 Jan; 58(2):994-1004. PubMed ID: 25522110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Bacterial Nitric Oxide Synthase with Aminoquinoline-Based Inhibitors.
    Holden JK; Lewis MC; Cinelli MA; Abdullatif Z; Pensa AV; Silverman RB; Poulos TL
    Biochemistry; 2016 Oct; 55(39):5587-5594. PubMed ID: 27607918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor Bound Crystal Structures of Bacterial Nitric Oxide Synthase.
    Holden JK; Dejam D; Lewis MC; Huang H; Kang S; Jing Q; Xue F; Silverman RB; Poulos TL
    Biochemistry; 2015 Jul; 54(26):4075-82. PubMed ID: 26062720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureus.
    Holden JK; Kang S; Beasley FC; Cinelli MA; Li H; Roy SG; Dejam D; Edinger AL; Nizet V; Silverman RB; Poulos TL
    Chem Biol; 2015 Jun; 22(6):785-92. PubMed ID: 26091171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthase and structure-based inhibitor design.
    Poulos TL; Li H
    Nitric Oxide; 2017 Feb; 63():68-77. PubMed ID: 27890696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design.
    Fedorov R; Vasan R; Ghosh DK; Schlichting I
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):5892-7. PubMed ID: 15071192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.
    Hagmann WK; Caldwell CG; Chen P; Durette PL; Esser CK; Lanza TJ; Kopka IE; Guthikonda R; Shah SK; MacCoss M; Chabin RM; Fletcher D; Grant SK; Green BG; Humes JL; Kelly TM; Luell S; Meurer R; Moore V; Pacholok SG; Pavia T; Williams HR; Wong KK
    Bioorg Med Chem Lett; 2000 Sep; 10(17):1975-8. PubMed ID: 10987430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors.
    Ji H; Li H; Flinspach M; Poulos TL; Silverman RB
    J Med Chem; 2003 Dec; 46(26):5700-11. PubMed ID: 14667223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Roles of Nitric Oxide Synthase in Bacterial Physiology.
    Hutfless EH; Chaudhari SS; Thomas VC
    Adv Microb Physiol; 2018; 72():147-191. PubMed ID: 29778214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational studies of competitive inhibitors of nitric oxide synthase (NOS) enzymes: towards the development of powerful and isoform-selective inhibitors.
    Tafi A; Angeli L; Venturini G; Travagli M; Corelli F; Botta M
    Curr Med Chem; 2006; 13(16):1929-46. PubMed ID: 16842203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neuronal nitric oxide synthase by 4-amino pteridine derivatives: structure-activity relationship of antagonists of (6R)-5,6,7,8-tetrahydrobiopterin cofactor.
    Fröhlich LG; Kotsonis P; Traub H; Taghavi-Moghadam S; Al-Masoudi N; Hofmann H; Strobel H; Matter H; Pfleiderer W; Schmidt HH
    J Med Chem; 1999 Oct; 42(20):4108-21. PubMed ID: 10514281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of selective and potent inhibitors of neuronal nitric oxide synthase.
    Lowe JA; Qian W; Volkmann RA; Heck S; Nowakowski J; Nelson R; Nolan C; Liston D; Ward K; Zorn S; Johnson C; Vanase M; Faraci WS; Verdries KA; Baxter J; Doran S; Sanders M; Ashton M; Whittle P; Stefaniak M
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2569-72. PubMed ID: 10498210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases.
    Matter H; Kumar HS; Fedorov R; Frey A; Kotsonis P; Hartmann E; Fröhlich LG; Reif A; Pfleiderer W; Scheurer P; Ghosh DK; Schlichting I; Schmidt HH
    J Med Chem; 2005 Jul; 48(15):4783-92. PubMed ID: 16033258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase.
    Raman CS; Li H; Martásek P; Babu BR; Griffith OW; Masters BS; Poulos TL
    J Biol Chem; 2001 Jul; 276(28):26486-91. PubMed ID: 11331290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology and chemistry of the inhibition of nitric oxide synthases by pteridine-derivatives as therapeutic agents.
    Matter H; Kotsonis P
    Med Res Rev; 2004 Sep; 24(5):662-84. PubMed ID: 15224385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological testing of potential heme-coordinating nitric oxide synthase inhibitors.
    Litzinger EA; Martásek P; Roman LJ; Silverman RB
    Bioorg Med Chem; 2006 May; 14(9):3185-98. PubMed ID: 16431112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.
    Fischmann TO; Hruza A; Niu XD; Fossetta JD; Lunn CA; Dolphin E; Prongay AJ; Reichert P; Lundell DJ; Narula SK; Weber PC
    Nat Struct Biol; 1999 Mar; 6(3):233-42. PubMed ID: 10074942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.
    Garcin ED; Arvai AS; Rosenfeld RJ; Kroeger MD; Crane BR; Andersson G; Andrews G; Hamley PJ; Mallinder PR; Nicholls DJ; St-Gallay SA; Tinker AC; Gensmantel NP; Mete A; Cheshire DR; Connolly S; Stuehr DJ; Aberg A; Wallace AV; Tainer JA; Getzoff ED
    Nat Chem Biol; 2008 Nov; 4(11):700-7. PubMed ID: 18849972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.
    Wang HY; Qin Y; Li H; Roman LJ; Martásek P; Poulos TL; Silverman RB
    J Med Chem; 2016 May; 59(10):4913-25. PubMed ID: 27050842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.